These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 17257478

  • 1. A retrospective pooled analysis of duloxetine safety in 23,983 subjects.
    Gahimer J, Wernicke J, Yalcin I, Ossanna MJ, Wulster-Radcliffe M, Viktrup L.
    Curr Med Res Opin; 2007 Jan; 23(1):175-84. PubMed ID: 17257478
    [Abstract] [Full Text] [Related]

  • 2. Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials.
    Hudson JI, Wohlreich MM, Kajdasz DK, Mallinckrodt CH, Watkin JG, Martynov OV.
    Hum Psychopharmacol; 2005 Jul; 20(5):327-41. PubMed ID: 15912562
    [Abstract] [Full Text] [Related]

  • 3. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM, Mallinckrodt CH, Prakash A, Watkin JG, Carter WP.
    Depress Anxiety; 2007 Jul; 24(1):41-52. PubMed ID: 16845641
    [Abstract] [Full Text] [Related]

  • 4. Duloxetine in the treatment of major depressive disorder: comparisons of safety and tolerability in male and female patients.
    Stewart DE, Wohlreich MM, Mallinckrodt CH, Watkin JG, Kornstein SG.
    J Affect Disord; 2006 Aug; 94(1-3):183-9. PubMed ID: 16780958
    [Abstract] [Full Text] [Related]

  • 5. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA, Prakash A, Arnold LM, Aaronson ST, Mallinckrodt CH, Wohlreich MM.
    Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
    [Abstract] [Full Text] [Related]

  • 6. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG, Pritchett YL, Kajdasz DK, Bauer M, Jain R, Russell JM, Walker DJ, Spencer KA, Froud DM, Raskin J, Thase ME.
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [Abstract] [Full Text] [Related]

  • 7. Safety and tolerability of duloxetine in the acute management of diabetic peripheral neuropathic pain: analysis of pooled data from three placebo-controlled clinical trials.
    Hall JA, Wang F, Oakes TM, Utterback BG, Crucitti A, Acharya N.
    Expert Opin Drug Saf; 2010 Jul; 9(4):525-37. PubMed ID: 20465525
    [Abstract] [Full Text] [Related]

  • 8. Duloxetine for the treatment of stress urinary incontinence in women: an integrated analysis of safety.
    Hurley DJ, Turner CL, Yalcin I, Viktrup L, Baygani SK.
    Eur J Obstet Gynecol Reprod Biol; 2006 Mar 01; 125(1):120-8. PubMed ID: 16188367
    [Abstract] [Full Text] [Related]

  • 9. Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder.
    Arnold LM, Hudson JI, Wang F, Wohlreich MM, Prakash A, Kajdasz DK, Chappell AS.
    Clin J Pain; 2009 Mar 01; 25(6):461-8. PubMed ID: 19542792
    [Abstract] [Full Text] [Related]

  • 10. A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia.
    Chappell AS, Littlejohn G, Kajdasz DK, Scheinberg M, D'Souza DN, Moldofsky H.
    Clin J Pain; 2009 Jun 01; 25(5):365-75. PubMed ID: 19454869
    [Abstract] [Full Text] [Related]

  • 11. Long-term safety of duloxetine during open-label compassionate use treatment of patients who completed previous duloxetine clinical trials.
    Pangallo BA, Zhang Q, Desaiah D, Perahia DG, Detke MJ, Kennedy SH.
    Curr Med Res Opin; 2010 Nov 01; 26(11):2643-51. PubMed ID: 20932222
    [Abstract] [Full Text] [Related]

  • 12. Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine.
    Greist J, McNamara RK, Mallinckrodt CH, Rayamajhi JN, Raskin J.
    Clin Ther; 2004 Sep 01; 26(9):1446-55. PubMed ID: 15531007
    [Abstract] [Full Text] [Related]

  • 13. Safety and tolerability of duloxetine at 60 mg once daily in elderly patients with major depressive disorder.
    Raskin J, Wiltse CG, Dinkel JJ, Walker DJ, Desaiah D, Katona C.
    J Clin Psychopharmacol; 2008 Feb 01; 28(1):32-8. PubMed ID: 18204338
    [Abstract] [Full Text] [Related]

  • 14. Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia.
    Mease PJ, Russell IJ, Kajdasz DK, Wiltse CG, Detke MJ, Wohlreich MM, Walker DJ, Chappell AS.
    Semin Arthritis Rheum; 2010 Jun 01; 39(6):454-64. PubMed ID: 19152958
    [Abstract] [Full Text] [Related]

  • 15. Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorder.
    Perahia DG, Kajdasz DK, Desaiah D, Haddad PM.
    J Affect Disord; 2005 Dec 01; 89(1-3):207-12. PubMed ID: 16266753
    [Abstract] [Full Text] [Related]

  • 16. Duloxetine compared with placebo for treating women with symptoms of overactive bladder.
    Steers WD, Herschorn S, Kreder KJ, Moore K, Strohbehn K, Yalcin I, Bump RC, Duloxetine OAB Study Group.
    BJU Int; 2007 Aug 01; 100(2):337-45. PubMed ID: 17511767
    [Abstract] [Full Text] [Related]

  • 17. Duloxetine in the treatment of major psychiatric and neuropathic disorders.
    Müller N, Schennach R, Riedel M, Möller HJ.
    Expert Rev Neurother; 2008 Apr 01; 8(4):527-36. PubMed ID: 18416656
    [Abstract] [Full Text] [Related]

  • 18. Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trials.
    Allgulander C, Hartford J, Russell J, Ball S, Erickson J, Raskin J, Rynn M.
    Curr Med Res Opin; 2007 Jun 01; 23(6):1245-52. PubMed ID: 17559726
    [Abstract] [Full Text] [Related]

  • 19. Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil.
    Lee P, Shu L, Xu X, Wang CY, Lee MS, Liu CY, Hong JP, Ruschel S, Raskin J, Colman SA, Harrison GA.
    Psychiatry Clin Neurosci; 2007 Jun 01; 61(3):295-307. PubMed ID: 17472599
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.